NCT06724263: A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors
- State
- Not started
- Phase
- Phase 2
- People
- 120 planned
- Started
- Dec 2024
- Primary completion
- Aug 2026
- Arms
- B1962
- Results
- None posted
- 9 Dec 2024: Trial registered